艾万拓 AVTR

Corey Walker is our President of Laboratory Solutions, a position he has held since April 2025. Prior to joining Avantor, Mr. Walker was President and CEO of ILC Dover, a life sciences company, from November 2021 to June 2024, and President, DCP Midstream, an energy company, from March 2020 to November 2021. From 2016 to 2020, Mr. Walker was an Executive Vice President at Avantor and led the Americas region as well as the global Biomaterials and Electronic Materials businesses.

Emmanuel Ligner is our President and Chief Executive Officer, a position he has held since August 2025. Prior to joining the Company, Mr. Ligner served as Chief Executive Officer at Cerba HealthCare from March 2024 to March 2025. Prior to that, Mr. Ligner was President and Chief Executive Officer of Cytiva and a Group Executive of Danaher Corporation, a life sciences company, from April 2020 to March 2024. Before Cytiva, he held several leadership positions at GE in North America, Europe, the Middle East and Africa, culminating in his appointment to President and Chief Executive Officer of GE Life Sciences. Mr. Ligner began his career in Japan with Otsuka Pharmaceuticals before joining Abbott Japan.

Claudius Sokenu is our Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary, a position he has held since July 2023. Prior to joining Avantor, Mr. Sokenu was General Counsel, Corporate Secretary and Chief Administrative Officer at Unisys, a technology company, from May 2022 to June 2023, Senior Vice President and Global Deputy General Counsel at Cognizant, an information technology services and consulting company, from March 2020 to April 2022 and Deputy General Counsel, Global Head of Litigation, Investigations and Ethics & Compliance from May 2017 to October 2018. Previously, he was a partner at Shearman & Sterling LLP and Arnold & Porter LLP.

Mr. Summe has served on our Board since May 2020, is the Chair of the Nominating & Governance Committee and a member of the Compensation & Human Resources Committee. Mr. Summe is the Managing Partner of Glen Capital Partners, an investment fund, which he founded in 2014. He is also a Senior Advisor to Star Mountain Capital. He currently serves on the board of directors of NXP Semiconductors NV, Wheels Up Experience, Inc., and is the chair of the board of GRAIL, Inc. Previously, he was the Managing Director and Vice Chairman of Global Buyout at The Carlyle Group and a Senior Advisor to Goldman Sachs Capital Partners. He also spent 11 years as the Chairman and Chief Executive Officer of PerkinElmer. Before PerkinElmer, Mr. Summe was with AlliedSignal, now Honeywell International, serving as the President of General Aviation Avionics, President of the Aerospace Engines Group and President of the Automotive Products Group. He was also a partner at McKinsey & Co. In the past five years, Mr. Summe served as a director of State Street Corporation (2001 to May 2025), Virgin Orbit Holdings USA (2021 to 2023) and as co-founder of NextGen Acquisition Corp I & II (2020 to 2021). Mr. Summe holds an MBA with distinction from The Wharton School of the University of Pennsylvania, a master's degree in electrical engineering from University of Cincinnati and a bachelor's degree in electrical engineering from University of Kentucky. He is in the Hall of Distinction at the University of Kentucky.

Mr. Massaro has served on our Board since November 2021 and is currently Chair of the Audit & Finance Committee. Mr. Massaro is currently Vice Chair, Engineered Components Group at Aptiv PLC, a global technology company, a position he has held since November 2024. Prior to that, he served as Aptiv's Chief Financial Officer and Senior Vice President, Business Operations from March 2016 to November 2024. Earlier in his career, he held several senior executive positions at Aptiv, including Vice President and Corporate Controller. He was also Chief Financial Officer at inVentiv Health and a Managing Director at Liberty Lane Partners. Mr. Massaro earned an MBA and a master of science in accounting from Northeastern University. He holds a bachelor of science in finance and economics from Bentley University.

Dr. Severino has served on our Board since April 2020 and is currently Chair of the Compensation & Human Resources Committee. He also is currently a member of the Science & Technology Committee. Dr. Severino currently serves as Chief Executive Officer of Tessera Therapeutics, Inc., a biotechnology company, a position he has held since June 2022. Prior to that, he served as Vice Chairman and President of AbbVie Inc., a pharmaceutical company, as well as its Executive Vice President, Research & Development and as its Chief Scientific Officer. He also spent 10 years at Amgen, Inc., serving in a variety of leadership positions, including Senior Vice President, Global Development, and Chief Medical Officer. Dr. Severino also served on the board of directors for the Field Museum in Chicago, Illinois from 2015 through 2022. He earned an M.D. from Johns Hopkins University, completing his residency and fellowship training at Massachusetts General Hospital and Harvard Medical School, as well as a bachelor's degree in biochemistry from the University of Maryland.

On October 1, 2025, the Board of Directors of Avantor, Inc elected Gregory Lucier as a director, effective as of October 3, 2025. Mr. Lucier, age 61, currently serves as the Executive Chairman and Chief Executive Officer of Corza Medical, a surgical technologies company, since 2021. Prior to Corza Medical, Mr. Lucier served as the Chairman and Chief Executive Officer of NuVasive, Inc., a global technology leader in minimally invasive spine and orthopedic surgery, from 2015 to 2021. Prior to NuVasive, Mr. Lucier served as Chairman and CEO of Life Technologies, a global life sciences company, from 2003 to 2014. Mr. Lucier's early career included roles as a corporate officer of General Electric Company and as an executive at GE Medical Systems Information Technologies. He currently serves on the board of directors of Maravai Lifesciences Holdings, Inc. and as non-executive chairman of the board of Dentsply Sirona, Inc. In the past five years, he has served as a director on the boards of each of Catalent Inc. and PhenomeX Inc. Mr. Lucier holds an MBA from Harvard Business School and a bachelor's degree in industrial engineering from Pennsylvania State University.

On December 4, 2025, the Board of Directors of Avantor, Inc., elected Sanjeev Mehra as a director. Mr. Mehra, age 66, currently serves as the Co-Founder and Managing Partner of Periphas Capital, a private equity investing firm focused on technology enabled, business services, consumer and industrial companies, since 2017. Prior to Periphas Capital, Mr. Mehra served in a variety of positions at Goldman Sachs, a global investment banking, securities and investment management firm, from 1986 to 2017, including Partner from 1998 to 2017, and held a range of other senior positions, including Vice Chairman of the Global Private Equity business, and prior to that, co-head of the Americas Private Equity business. Mr. Mehra was also a founding member of Goldman Sachs' Principal Investment Area (PIA), the firm's private investing arm of its Merchant Banking Division, and served on the PIA Investment Committee from 1998 to 2017. Prior to Goldman Sachs, Mr. Mehra was an Analyst at McKinsey & Company, a management consulting firm, from 1982 to 1984. He currently serves on the board of directors of OPENLANE, Inc. In the past five years, he served as a director of Periphas Capital Partnering Corporation. Mr. Mehra holds an MBA from Harvard Business School and a bachelor's degree in economics from Harvard College.

On March 26, 2026, Company announced that Mr. Steven W. Eck will be appointed as Interim Chief Financial Officer effective resignation of previous CFO. Mr. Eck joined the Company in 2019 as Senior Vice President and Chief Accounting Officer. Before joining the Company, Mr. Eck previously served as the principal accounting officer of CSS Industries, Inc., a consumer products company, from June 2018 to April 2019. Prior to joining CSS Industries in 2018, Mr. Eck served as a Vice President of Finance and in other senior level finance positions at Fidelity National Information Systems, a financial technology and payments company, between 2014 and 2018. Mr. Eck also served in senior accounting roles at Gardner Denver, Inc., an industrial manufacturer, and at General Electric Company, a high-tech industrial company, between 2010 and 2014. Mr. Eck began his professional career in 2001 at Deloitte & Touche LLP. Mr. Eck earned a B.A. in accounting from Muhlenberg College and is a Certified Public Accountant. Effective 21st September 2026, Steven Eck, the Company's Senior Vice President, Interim Chief Financial Officer and Chief Accounting Officer, will cease serving as the Interim Chief Financial Officer, but will continue in his position as Senior Vice President and Chief Accounting Officer.

Todd Garner was appointed as Executive Vice President and Chief Financial Officer with effect from 21st September 2026. Mr. Garner most recently served as Executive Vice President and Chief Financial Officer of CONMED Corporation from January 2018 to March 2026. He brings more than 30 years of finance, operational, and public company leadership experience. Prior to CONMED, he served in several leadership roles at C.R. Bard, Inc. from 2003 to 2017, including Vice President, Investor Relations from 2011 to 2017, Vice President, Controller (Division Chief Financial Officer) from 2007 to 2011, Director of Financial Reporting from 2005 to 2007, and Controller of the Reynosa Operations from 2003 to 2005, where he helped support significant shareholder value creation and business growth. Mr. Garner holds a bachelor's degree in accounting from Brigham Young University, an MBA from the University of Texas Rio Grande Valley, and is a Certified Public Accountant.

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Ludovic Brellier will join the company as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer on May 1, 2026. In this role, Mr. Brellier will be responsible for growing the BMP business and improving operational performance. He will also lead the Revival Management Office, driving transformation initiatives across the enterprise. Mr. Brellier is an accomplished executive with deep operational experience across healthcare and strategic business transformation. He joins Avantor from Danaher, where he was most recently President of Cytiva's Hardware Solutions business, leading five business units responsible for early innovation through manufacturing and commercialization of services for the biopharma industry. While at Cytiva, Mr. Brellier previously served as President of Integrated Solutions & Services and VP Business Operations. He also led the effort to establish Cytiva as a standalone operating company within Danaher as well as the integration of Pall Life Sciences and Cytiva.

Simon Dingemans has been appointed as a director, effective January 2, 2026. Mr. Dingemans, age 62, most recently served in senior leadership roles at The Carlyle Group, a global investment management firm, as Senior Advisor from 2022 to 2024 and as Managing Director and Partner, UK Buyouts from 2020 to 2022. Prior to his roles at The Carlyle Group, Mr. Dingemans served as the Chief Financial Officer of GSK plc, a global biopharmaceutical company, from 2011 to 2019. Mr. Dingemans also served in a variety of positions at Goldman Sachs, a global investment banking, securities and investment management firm, from 1995 to 2010, including Partner and held leadership roles overseeing the UK Investment Banking and European Mergers from 2000 to 2010, and Managing Director from 1995 to 2000. Prior to Goldman Sachs, Mr. Dingemans spent ten years at SG Warburg, an investment bank, in positions of increasing responsibility. He currently serves on the boards of directors of Vodafone Group Plc, WPP plc and Genomics Limited. Mr. Dingemans holds both a master's degree and a bachelor's degree in geography from the University of Oxford.

Mary Blenn is our Executive Vice President and Chief Operating Officer, a position she has held since November 2025. Prior to joining the Company, Ms. Blenn, age 53, provided consulting services to life sciences and medtech companies through her personal consulting firm Blenn Consulting from April 2024 to October 2025. Prior to that, Ms. Blenn served as Senior Vice President, Global Operations and Supply Chain of Cytiva, a life sciences company, from April 2020 to July 2023 and in several senior leadership roles at GE Healthcare from 1998 through 2020.

Brittany Hankamer is our Executive Vice President and Chief Human Resources Officer, a position she has held since August 2023. Prior to assuming her current position, Ms. Hankamer served as Avantor's Senior Vice President of Talent and People Operations from May 2021 to August 2023 and as Vice President, Human Resources from September 2019 to May 2021. Prior to joining Avantor, Ms. Hankamer was Vice President of Human Resources at Conquest Completion Services, LLC from May 2018 to September 2019.

James Bramwell is our Executive Vice President, Americas, a position he has held since October 2022. Prior to his current role, he served as Avantor's Executive Vice President, Strategic Partners from November 2017 to October 2022 and as Senior Vice President, Strategic Partners and Global Export of VWR from March 2016 to November 2017. On January 6, 2025, Avantor, Inc. was notified by Jim Bramwell, its Executive Vice President, Sales and Customer Excellence, of his intention to retire from the Company on or around June 30, 2025, and pursue a full-time service opportunity within his faith.